文献速递慢阻肺

身体衰弱与COPD发病及预期寿命的关联:一项基于人群的队列研究

Association of Physical Frailty With Incidence and Life Expectancy of COPD: A Population-Based Cohort Study.
PubMed 文献 · Chest · 2025-04-19

该研究基于英国生物银行队列,纳入412,351名无COPD成人及60,584例COPD患者,评估身体衰弱与COPD发病及死亡的关系。中位随访13.5年,记录10,695例新发COPD。衰弱和衰弱前期均显著增加COPD风险,且与遗传易感性和PRISm存在交互作用;在COPD患者中,衰弱与预期寿命缩短相关。

要点

  • 衰弱者COPD风险增加(HR 2.21),衰弱前期风险亦增加(HR 1.45)。
  • 遗传易感性和PRISm与衰弱对COPD发生产生显著交互作用。
  • 45岁COPD患者中,衰弱者预期寿命缩短男性8.49年、女性7.67年。

核心结论

  • 衰弱和衰弱前期增加COPD发病风险,并与COPD患者预期寿命缩短相关。
  • 应早期识别和管理衰弱以降低COPD风险并改善治疗策略。

研究设计与样本

  • 基于英国生物银行的前瞻性队列研究,纳入基线无COPD成人412,351名(平均年龄56.1±8.1岁,男性44.3%)和COPD患者60,584例(平均年龄59.2±7.4岁,男性55.1%)。
  • 衰弱表型依据5个组分评估:体重下降、疲惫、低体力活动、步速减慢、握力下降。
  • 采用Cox比例风险回归模型评估遗传易感性、PRISm和衰弱与COPD发生的关联,并用寿命表法估计COPD患者因衰弱导致的预期寿命损失。

主要发现

  • 中位随访13.5年,记录10,695例新发COPD。
  • 多变量调整模型中,衰弱与COPD风险增加显著相关(HR 2.21;95%CI 2.06-2.37),衰弱前期亦相关(HR 1.45;95%CI 1.39-1.51)。
  • 45岁COPD患者中,衰弱者预期寿命较非衰弱者缩短男性8.49年、女性7.67年;衰弱前期者分别缩短3.27年和2.78年。

临床怎么用

  • 在COPD风险评估和治疗策略中,应考虑纳入衰弱的早期筛查与管理。
  • 对衰弱及衰弱前期个体应加强COPD预防干预,以降低发病风险。
  • 对COPD患者评估衰弱状态有助于识别预期寿命缩短的高危人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The bidirectional relationship between frailty and COPD is documented. However, longitudinal studies examining the combined effects of genetic predisposition and preserved ratio impaired spirometry (PRISm) on frailty in COPD development are lacking. RESEARCH QUESTION: What is the association between physical frailty and the incidence and mortality of COPD, and how do genetic predisposition and PRISm modify this association? STUDY DESIGN AND METHODS: We included 412,351 adults without COPD (mean age ± SD, 56.1 ± 8.1 years; 44.3% male) and 60,584 patients with COPD (mean age ± SD, 59.2 ± 7.4 years; 55.1% male) at baseline in the UK Biobank cohort. Frailty phenotypes were assessed using 5 components, including weight loss, exhaustion, low physical activity, slow gait speed, and low grip strength. Cox proportional hazards regression models were used to evaluate the association of genetic predisposition, PRISm, and frailty with COPD development. Life expectancy reductions due to frailty were estimated using life table methods in patients with COPD. RESULTS: During a median follow-up of 13.5 years, 10,695 incident COPD cases were recorded. In the multivariable-adjusted model, frailty and prefrailty were significantly associated with an increased risk of COPD (hazard ratio, 2.21; 95% CI, 2.06-2.37 for frailty; hazard ratio, 1.45; 95% CI, 1.39-1.51 for prefrailty). Significant interactions were observed between genetic predisposition and frailty (P for interaction = .0252), and between PRISm and frailty (P for interaction = .0027), in the development of COPD. Among patients with COPD at 45 years of age, frailty was associated with a reduction in life expectancy of 8.49 years for male individuals and 7.67 years for female individuals, whereas prefrailty was associated with reductions of 3.27 and 2.78 years, respectively, compared with their nonfrail counterparts. INTERPRETATION: The results of this study indicate that frailty and prefrailty increase COPD risk and are linked to reduced life expectancy in patients with COPD, highlighting the need for early detection and management of frailty in COPD risk reduction and treatment strategies.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Liu C, Xiong H, Han X, et al. Association of Physical Frailty With Incidence and Life Expectancy of COPD: A Population-Based Cohort Study. Chest. 2025. PMID: 40258513. doi:10.1016/j.chest.2025.03.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。